140 related articles for article (PubMed ID: 14600801)
1. AMPA-receptor activation is involved in the antiamnesic effect of DM 232 (unifiram) and DM 235 (sunifiram).
Galeotti N; Ghelardini C; Pittaluga A; Pugliese AM; Bartolini A; Manetti D; Romanelli MN; Gualtieri F
Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec; 368(6):538-45. PubMed ID: 14600801
[TBL] [Abstract][Full Text] [Related]
2. Aniracetam, 1-BCP and cyclothiazide differentially modulate the function of NMDA and AMPA receptors mediating enhancement of noradrenaline release in rat hippocampal slices.
Pittaluga A; Bonfanti A; Arvigo D; Raiteri M
Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):272-9. PubMed ID: 10344525
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and preliminary pharmacological evaluation of new analogues of DM232 (unifiram) and DM235 (sunifiram) as cognition modulators.
Martini E; Norcini M; Ghelardini C; Manetti D; Dei S; Guandalini L; Melchiorre M; Pagella S; Scapecchi S; Teodori E; Romanelli MN
Bioorg Med Chem; 2008 Dec; 16(23):10034-42. PubMed ID: 18954993
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological characterization of DM232 (unifiram) and DM235 (sunifiram), new potent cognition enhancers.
Romanelli MN; Galeotti N; Ghelardini C; Manetti D; Martini E; Gualtieri F
CNS Drug Rev; 2006; 12(1):39-52. PubMed ID: 16834757
[TBL] [Abstract][Full Text] [Related]
5. Substituted piperazines as nootropic agents: 2- or 3-phenyl derivatives structurally related to the cognition-enhancer DM235.
Guandalini L; Martino MV; Di Cesare Mannelli L; Bartolucci G; Melani F; Malik R; Dei S; Floriddia E; Manetti D; Orlandi F; Teodori E; Ghelardini C; Romanelli MN
Bioorg Med Chem Lett; 2015 Apr; 25(8):1700-1704. PubMed ID: 25813160
[TBL] [Abstract][Full Text] [Related]
6. DM235 (sunifiram): a novel nootropic with potential as a cognitive enhancer.
Ghelardini C; Galeotti N; Gualtieri F; Romanelli MN; Bucherelli C; Baldi E; Bartolini A
Naunyn Schmiedebergs Arch Pharmacol; 2002 Jun; 365(6):419-26. PubMed ID: 12070754
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationship studies on unifiram (DM232) and sunifiram (DM235), two novel and potent cognition enhancing drugs.
Scapecchi S; Martini E; Manetti D; Ghelardini C; Martelli C; Dei S; Galeotti N; Guandalini L; Novella Romanelli M; Teodori E
Bioorg Med Chem; 2004 Jan; 12(1):71-85. PubMed ID: 14697772
[TBL] [Abstract][Full Text] [Related]
8. Enantioselective synthesis and preliminary pharmacological evaluation of the enantiomers of unifiram (DM232), a potent cognition-enhancing agent.
Martini E; Ghelardini C; Bertucci C; Dei S; Gualtieri F; Guandalini L; Manetti D; Scapecchi S; Teodori E; Romanelli MN
Med Chem; 2005 Sep; 1(5):473-80. PubMed ID: 16787332
[TBL] [Abstract][Full Text] [Related]
9. Novel nootropic drug sunifiram enhances hippocampal synaptic efficacy via glycine-binding site of N-methyl-D-aspartate receptor.
Moriguchi S; Tanaka T; Narahashi T; Fukunaga K
Hippocampus; 2013 Oct; 23(10):942-51. PubMed ID: 23733502
[TBL] [Abstract][Full Text] [Related]
10. Influence of ring size on the cognition-enhancing activity of DM235 and MN19, two potent nootropic drugs.
Guandalini L; Martini E; Di Cesare Mannelli L; Dei S; Manetti D; Scapecchi S; Teodori E; Ghelardini C; Romanelli MN
Bioorg Med Chem Lett; 2012 Mar; 22(5):1936-9. PubMed ID: 22325944
[TBL] [Abstract][Full Text] [Related]
11. Unifi nootropics from the lab to the web: a story of academic (and industrial) shortcomings.
Gualtieri F
J Enzyme Inhib Med Chem; 2016; 31(2):187-94. PubMed ID: 25831025
[TBL] [Abstract][Full Text] [Related]
12. Glutamate-stimulated release of norepinephrine in hippocampal slices of animal models of attention-deficit/hyperactivity disorder (spontaneously hypertensive rat) and depression/anxiety-like behaviours (Wistar-Kyoto rat).
Howells FM; Russell VA
Brain Res; 2008 Mar; 1200():107-15. PubMed ID: 18295191
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and nootropic activity of new analogues of sunifiram and sapunifiram, two potent cognition-enhancers.
Martini E; Salvicchi A; Ghelardini C; Manetti D; Dei S; Guandalini L; Martelli C; Melchiorre M; Cellai C; Scapecchi S; Teodori E; Romanelli MN
Bioorg Med Chem; 2009 Nov; 17(21):7606-14. PubMed ID: 19786353
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and preliminary pharmacological evaluation of 1, 4-diazabicyclo[4.3.0]nonan-9-ones as a new class of highly potent nootropic agents.
Manetti D; Ghelardini C; Bartolini A; Bellucci C; Dei S; Galeotti N; Gualtieri F; Romanelli MN; Scapecchi S; Teodori E
J Med Chem; 2000 May; 43(10):1969-74. PubMed ID: 10821709
[TBL] [Abstract][Full Text] [Related]
15. Activity of putative cognition enhancers in kynurenate test performed with human neocortex slices.
Pittaluga A; Pattarini R; Andrioli GC; Viola C; Munari C; Raiteri M
J Pharmacol Exp Ther; 1999 Jul; 290(1):423-8. PubMed ID: 10381808
[TBL] [Abstract][Full Text] [Related]
16. [Anti-amnestic activities of 3-hydroxy-3-pyrroline-2-one derivatives].
Shuklina NS; Kolla VE
Eksp Klin Farmakol; 2003; 66(6):12-5. PubMed ID: 14743703
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of N-methyl-D-aspartate-induced currents by the nootropic drug nefiracetam in rat cortical neurons.
Moriguchi S; Marszalec W; Zhao X; Yeh JZ; Narahashi T
J Pharmacol Exp Ther; 2003 Oct; 307(1):160-7. PubMed ID: 12805478
[TBL] [Abstract][Full Text] [Related]
18. Nobiletin, a citrus flavonoid with neurotrophic action, augments protein kinase A-mediated phosphorylation of the AMPA receptor subunit, GluR1, and the postsynaptic receptor response to glutamate in murine hippocampus.
Matsuzaki K; Miyazaki K; Sakai S; Yawo H; Nakata N; Moriguchi S; Fukunaga K; Yokosuka A; Sashida Y; Mimaki Y; Yamakuni T; Ohizumi Y
Eur J Pharmacol; 2008 Jan; 578(2-3):194-200. PubMed ID: 17976577
[TBL] [Abstract][Full Text] [Related]
19. 4-Aminopiperidine derivatives as a new class of potent cognition enhancing drugs.
Manetti D; Martini E; Ghelardini C; Dei S; Galeotti N; Guandalini L; Romanelli MN; Scapecchi S; Teodori E; Bartolini A; Gualtieri F
Bioorg Med Chem Lett; 2003 Jul; 13(14):2303-6. PubMed ID: 12824022
[TBL] [Abstract][Full Text] [Related]
20. The dual effect of CA1 NMDA receptor modulation on ACPA-induced amnesia in step-down passive avoidance learning task.
Nasehi M; Amin-Yavari S; Ebrahimi-Ghiri M; Torabi-Nami M; Zarrindast MR
Eur Neuropsychopharmacol; 2015 Apr; 25(4):557-65. PubMed ID: 25680309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
